Form 8-K - Current report:
SEC Accession No. 0001104659-25-026135
Filing Date
2025-03-20
Accepted
2025-03-20 16:12:09
Documents
13
Period of Report
2025-03-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259835d1_8k.htm   iXBRL 8-K 24711
  Complete submission text file 0001104659-25-026135.txt   197751

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20250317.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20250317_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20250317_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT tm259835d1_8k_htm.xml XML 3685
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 25756563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)